Cost of increasing access to artemisinin combination therapy: The Cambodian experience
Background. Malaria-endemic countries are switching antimalarial drug policy from cheap ineffective monotherapies to artemisinin combination therapies (ACTs) for the treatment of Plasmodium falciparum malaria and the global community are considering setting up a global subsidy to fund their purchase...
Saved in:
Main Authors: | Shunmay Yeung, Wim Van Damme, Duong Socheat, Nicholas J. White, Anne Mills |
---|---|
Other Authors: | London School of Hygiene & Tropical Medicine |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/19313 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Access to artemisinin combination therapy for malaria in remote areas of Cambodia
by: Shunmay Yeung, et al.
Published: (2018) -
Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices
by: Shunmay Yeung, et al.
Published: (2018) -
Artemisinin combination therapy for vivax malaria
by: Nicholas M. Douglas, et al.
Published: (2018) -
Artemisinin resistance: Current status and scenarios for containment
by: Arjen M. Dondorp, et al.
Published: (2018) -
Artemisinin-based combinations
by: Elizabeth A. Ashley, et al.
Published: (2018)